In a notable crackdown on pharmaceutical industry malpractices, Massachusetts Attorney General Andrea Joy Campbell has brought home a $1.6 million win for the state's Medicaid program. This sum is part of a larger $202 million settlement involving Gilead Sciences, Inc. and several states, addressing accusations of illegal kickbacks inflating prescriptions for HIV medications. The facts were laid bare as Campbell stated, "When a company pays kickbacks to health care providers to increase its own bottom line, it not only violates our laws; it also places an unfair burden on our crucial taxpayer-funded health care system relied upon by thousands of Massachusetts residents," as stated by the Office of the Attorney General.
The details of the multi-state settlement were unveiled today, arising from a lawsuit initially filed in 2016 in the United States District Court for the Southern District of New York. It was triggered by claims that Gilead Sciences sought to wrongly influence healthcare providers' medication prescribing habits by compensating them with meals, travel expenses, and speaking fees. These kickbacks, offered from 2011 through 2017, were seen primarily as a tactic to deliberately drive up sales of Gilead's HIV drugs, contributing to the submission of false claims to state Medicaid programs. In order to swiftly settle the allegations, Gilead has agreed to pay out a hefty sum, accepting responsibility for the conduct via extensive factual admissions, according to the Office of the Attorney General.
The investigation, led by the National Association of Medicaid Fraud Control Units (NAMFCU) and with active participation from numerous state attorneys general, marks a vigorous adherence to the enforcement of laws against corporate fraud. Massachusetts, at the forefront of this action, stands to bolster its Medicaid funds thanks to the diligent work of Assistant Attorneys General Kevin O’Keefe and Scott Grannemann, both from the AG's Medicaid Fraud Division, and with assistance from MassHealth. This coordinated effort was key to reaching the settlement confirmed by AG Campbell. "This settlement puts pharmaceutical companies on notice that we will not tolerate unlawful behavior," the Office of the Attorney General reported.
Massachusetts isn’t the only state getting money from the settlement—other states will also receive payments to help cover the costs illegally pushed onto Medicaid programs. The Attorney General’s Medicaid Fraud Division, with help from federal grants, continues to investigate and take legal action against healthcare fraud, protecting MassHealth’s finances. This settlement with Gilead sends a clear message to drug companies: trying to cheat the healthcare system will lead to serious legal consequences, as per the Office of the Attorney General.
.jpg){kind=link}